Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Piccolo

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Nature Materials|February 27, 2020
Publisher Correction: Reprogramming normal cells into tumour precursors requires ECM stiffness and oncogene-mediated changes of cell mechanical propertiesTito Panciera, Anna Citron, Daniele Di Biagio, et al.
Cell Systems|April 12, 2025
Combining spatial transcriptomics and ECM imaging in 3D for mapping cellular interactions in the tumor microenvironmentTancredi Massimo Pentimalli, Simon Schallenberg, Daniel León-Periñán, et al.
Cell|March 15, 2006
Emilin1 links TGF-beta maturation to blood pressure homeostasisLuca Zacchigna, Carmine Vecchione, Antonella Notte, et al.
Cell Stem Cell|December 19, 2017
YAP/TAZ-Dependent Reprogramming of Colonic Epithelium Links ECM Remodeling to Tissue RegenerationShiro Yui, Luca Azzolin, Martti Maimets, et al.
Nature Metabolism|June 21, 2022
A YAP/TAZ-TEAD signalling module links endothelial nutrient acquisition to angiogenic growthYu Ting Ong, Jorge Andrade, Max Armbruster, et al.
Nature Communications|September 25, 2020
ATR is essential for preservation of cell mechanics and nuclear integrity during interstitial migrationGururaj Rao Kidiyoor, Qingsen Li, Giulia Bastianello, et al.
Cancer Discovery|July 12, 2020
Disabled Homolog 2 Controls Prometastatic Activity of Tumor-Associated MacrophagesIlaria Marigo, Rosalinda Trovato, Francesca Hofer, et al.
Cell|April 2, 2026
A 3D morphogenetic blueprint for metastatic outgrowth in breast cancerRobin Caire, Roberta Bordo, Francesca Zanconato, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 9, 2024
EMID2 is a novel biotherapeutic for aggressive cancers identified by in vivo screeningAmbra Cappelletto, Edoardo Alfì, Nina Volf, et al.
Cell Chemical Biology|March 27, 2024
Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signalingKeith Graham, Philip Lienau, Benjamin Bader, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Nature Materials|February 27, 2020
Publisher Correction: Reprogramming normal cells into tumour precursors requires ECM stiffness and oncogene-mediated changes of cell mechanical propertiesTito Panciera, Anna Citron, Daniele Di Biagio, et al.
Cell Systems|April 12, 2025
Combining spatial transcriptomics and ECM imaging in 3D for mapping cellular interactions in the tumor microenvironmentTancredi Massimo Pentimalli, Simon Schallenberg, Daniel León-Periñán, et al.
Cell|March 15, 2006
Emilin1 links TGF-beta maturation to blood pressure homeostasisLuca Zacchigna, Carmine Vecchione, Antonella Notte, et al.
Cell Stem Cell|December 19, 2017
YAP/TAZ-Dependent Reprogramming of Colonic Epithelium Links ECM Remodeling to Tissue RegenerationShiro Yui, Luca Azzolin, Martti Maimets, et al.
Nature Metabolism|June 21, 2022
A YAP/TAZ-TEAD signalling module links endothelial nutrient acquisition to angiogenic growthYu Ting Ong, Jorge Andrade, Max Armbruster, et al.
Nature Communications|September 25, 2020
ATR is essential for preservation of cell mechanics and nuclear integrity during interstitial migrationGururaj Rao Kidiyoor, Qingsen Li, Giulia Bastianello, et al.
Cancer Discovery|July 12, 2020
Disabled Homolog 2 Controls Prometastatic Activity of Tumor-Associated MacrophagesIlaria Marigo, Rosalinda Trovato, Francesca Hofer, et al.
Cell|April 2, 2026
A 3D morphogenetic blueprint for metastatic outgrowth in breast cancerRobin Caire, Roberta Bordo, Francesca Zanconato, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 9, 2024
EMID2 is a novel biotherapeutic for aggressive cancers identified by in vivo screeningAmbra Cappelletto, Edoardo Alfì, Nina Volf, et al.
Cell Chemical Biology|March 27, 2024
Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signalingKeith Graham, Philip Lienau, Benjamin Bader, et al.
Pageof 11